Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Fumiaki Yokokawa. (2013) Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension. Expert Opinion on Drug Discovery 8:6, pages 673-690.
Read now
Read now
Articles from other publishers (21)
Jonas Rydfjord, Sara Roslin, Tamal Roy, Alaa Abbas, Marc Y. Stevens & Luke R. Odell. (2022)
Acyl Amidines by Pd-Catalyzed Aminocarbonylation: One-Pot Cyclizations and
11
C Labeling
. The Journal of Organic Chemistry 88:8, pages 5078-5089.
Crossref
Crossref
Jonas Rydfjord, Silav Al-Bazaz & Sara Roslin. (2022)
Palladium-Mediated Synthesis of [Carbonyl-
11
C]acyl Amidines from Aryl Iodides and Aryl Bromides and Their One-Pot Cyclization to
11
C-Labeled Oxadiazoles
. The Journal of Organic Chemistry 88:8, pages 5118-5126.
Crossref
Crossref
Daisuke Iijima, Hiroshi Sugama, Yoichi Takahashi, Miki Hirai, Yuko Togashi, Jianshu Xie, Jingkang Shen, Ying Ke, Hidenori Akatsuka, Takayuki Kawaguchi, Kei Takedomi, Akiko Kashima, Masashi Nishio, Yosuke Inui, Hikaru Yoneda, Guangxin Xia & Toru Iijima. (2022) Discovery of SPH3127: A Novel, Highly Potent, and Orally Active Direct Renin Inhibitor. Journal of Medicinal Chemistry 65:16, pages 10882-10897.
Crossref
Crossref
Daisuke Iijima, Hiroshi Sugama, Nobumasa Awai, Yoichi Takahashi, Yuko Togashi, Tohru Takebe, Jianshu Xie, Jingkang Shen, Ying Ke, Hidenori Akatsuka, Takayuki Kawaguchi, Kei Takedomi, Akiko Kashima, Masashi Nishio, Yosuke Inui, Hikaru Yoneda, Guangxin Xia & Toru Iijima. (2022) Discovery of Novel 2-Carbamoyl Morpholine Derivatives as Highly Potent and Orally Active Direct Renin Inhibitors. ACS Medicinal Chemistry Letters 13:8, pages 1351-1357.
Crossref
Crossref
Yasuhiro Imaeda, Michiko Tawada, Shinkichi Suzuki, Masaki Tomimoto, Mitsuyo Kondo, Naoki Tarui, Tsukasa Sanada, Ray Kanagawa, Gyorgy Snell, Craig A. Behnke, Keiji Kubo & Takanobu Kuroita. (2016) Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors. Bioorganic & Medicinal Chemistry 24:22, pages 5771-5780.
Crossref
Crossref
Yasuhiro Imaeda, Hidekazu Tokuhara, Yoshiyuki Fukase, Ray Kanagawa, Yumiko Kajimoto, Keiji Kusumoto, Mitsuyo Kondo, Gyorgy Snell, Craig A. Behnke & Takanobu Kuroita. (2016) Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor. ACS Medicinal Chemistry Letters 7:10, pages 933-938.
Crossref
Crossref
Holger Sellner, Sylvain Cottens, Frédéric Cumin, Claus Ehrhardt, Takatoshi Kosaka, Edwige Lorthiois, Nils Ostermann, Randy L. Webb, Dean F. Rigel, Trixie Wagner & Jürgen Maibaum. (2015) trans -3,4-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part II: Prime site exploration using an oxygen linker. Bioorganic & Medicinal Chemistry Letters 25:8, pages 1787-1791.
Crossref
Crossref
Edwige Lorthiois, Frederic Cumin, Claus Ehrhardt, Takatoshi Kosaka, Holger Sellner, Nils Ostermann, Eric Francotte, Trixie Wagner & Jürgen Maibaum. (2015) trans -(3 S ,4 S )-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part I: Prime site exploration using an amino linker. Bioorganic & Medicinal Chemistry Letters 25:8, pages 1782-1786.
Crossref
Crossref
Stephen Hanessian, Etienne Chénard, Sébastien Guesné & Jean-Philippe Cusson. (2014) Conception and Evolution of Stereocontrolled Strategies toward Functionalized 8-Aryloctanoic Acids Related to the Total Synthesis of Aliskiren. The Journal of Organic Chemistry 79:20, pages 9531-9545.
Crossref
Crossref
Megha S. Saraswat, Veeranjaneyulu Addepalli, Mukul Jain, Vishwanath D. Pawar & Rakesh B. Patel. (2014) Renoprotective activity of aliskiren, a renin inhibitor in cyclosporine A induced hypertensive nephropathy in dTG mice. Pharmacological Reports 66:1, pages 62-67.
Crossref
Crossref
Philip A CarpinoDeclan Flynn. (2012) Review of companies and drug classes in the 2007–2011 antihypertensive patent literature. Pharmaceutical Patent Analyst 1:1, pages 45-64.
Crossref
Crossref
Juan Tamargo & José López-Sendón. (2011) Novel therapeutic targets for the treatment of heart failure. Nature Reviews Drug Discovery 10:7, pages 536-555.
Crossref
Crossref
Yong Wu, Chen Shi, Xiaowei Sun, Xiaoming Wu & Hongbin Sun. (2011) Synthesis, biological evaluation and docking studies of octane-carboxamide based renin inhibitors with extended segments toward S3′ site of renin. Bioorganic & Medicinal Chemistry 19:14, pages 4238-4249.
Crossref
Crossref
Randy L. Webb, Nikolaus Schiering, Richard Sedrani & Jürgen Maibaum. (2010) Direct Renin Inhibitors as a New Therapy for Hypertension. Journal of Medicinal Chemistry 53:21, pages 7490-7520.
Crossref
Crossref
Bodo Scheiper, Hans Matter, Henning Steinhagen, Ulrich Stilz, Zsolt Böcskei, Valérie Fleury & Gary McCort. (2010) Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors. Bioorganic & Medicinal Chemistry Letters 20:21, pages 6268-6272.
Crossref
Crossref
Donald J. AbrahamColin M. Tice, Gerard M. McGeehan & David A. Claremon. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
239
266
.
Colin M. Tice & Suresh B. Singh. 2010. Aspartic Acid Proteases as Therapeutic Targets. Aspartic Acid Proteases as Therapeutic Targets
297
324
.
Austin Chen, Christopher Bayly, Olivier Bezençon, Sylvia Richard-Bildstein, Daniel Dubé, Laurence Dubé, Sébastien Gagné, Michel Gallant, Mireille Gaudreault, Erich Grimm, Robert Houle, Patrick Lacombe, Sébastien Laliberté, Jean-François Lévesque, Suzanna Liu, Dwight MacDonald, Bruce Mackay, David Martin, Dan McKay, David Powell, L’uboš Remeň, Stephen Soisson & Sylvie Toulmond. (2010) Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension. Bioorganic & Medicinal Chemistry Letters 20:7, pages 2204-2209.
Crossref
Crossref
Geraldine Harriman, Amy Elder & Indranath Ghosh. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
15
41
.
Yasuchika Yamaguchi, Keith Menear, Nissim-Claude Cohen, Robert Mah, Frédéric Cumin, Christian Schnell, Jeanette M. Wood & Jürgen Maibaum. (2009) The P1 N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin. Bioorganic & Medicinal Chemistry Letters 19:16, pages 4863-4867.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:3, pages 260-277.
Crossref
Crossref